Detalhe da pesquisa
1.
Anticuerpo monoclonal humanizado itolizumab (anti-cd6) en síndromes linfoproliferativos cd 6+. Experiencia preliminar / Itolizumab humanized monoclonal antibody (anti-cd6) in patients with cd6+ lymphoproliferative disorders. Preliminary experience
Rev. cuba. hematol. inmunol. hemoter
; 30(3): 0-0, jul.-set. 2014.
Artigo
em Espanhol
| LILACS | ID: lil-723763